Request for Covid-19 Impact Assessment of this Report

Take Action
Medical Devices

Global Age Related Macular Degeneration (AMD) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • GLO2794633
  • 134 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 

Scope of the Report:

This report studies the Age Related Macular Degeneration (AMD) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Age Related Macular Degeneration (AMD) market by product type and applications/end industries.

Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.

The global Age Related Macular Degeneration (AMD) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Age Related Macular Degeneration (AMD).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Bayer

F. HoffmannLa Roche

Regeneron

Novartis

Valeant

Pfizer

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Wet AMD

Dry AMD

Market Segment by Applications, can be divided into

Men

Woman

Table of Contents

1 Age Related Macular Degeneration (AMD) Market Overview

1.1 Product Overview and Scope of Age Related Macular Degeneration (AMD)

1.2 Classification of Age Related Macular Degeneration (AMD) by Types

1.2.1 Global Age Related Macular Degeneration (AMD) Revenue Comparison by Types (2017-2023)

1.2.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Types in 2017

1.2.3 Wet AMD

1.2.4 Dry AMD

1.3 Global Age Related Macular Degeneration (AMD) Market by Application

1.3.1 Global Age Related Macular Degeneration (AMD) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Men

1.3.3 Woman

1.4 Global Age Related Macular Degeneration (AMD) Market by Regions

1.4.1 Global Age Related Macular Degeneration (AMD) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Age Related Macular Degeneration (AMD) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Age Related Macular Degeneration (AMD) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Age Related Macular Degeneration (AMD) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Age Related Macular Degeneration (AMD) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Age Related Macular Degeneration (AMD) Status and Prospect (2013-2023)

1.5 Global Market Size of Age Related Macular Degeneration (AMD) (2013-2023)

2 Manufacturers Profiles

2.1 Bayer

2.1.1 Business Overview

2.1.2 Age Related Macular Degeneration (AMD) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bayer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

2.2 F. HoffmannLa Roche

2.2.1 Business Overview

2.2.2 Age Related Macular Degeneration (AMD) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

2.3 Regeneron

2.3.1 Business Overview

2.3.2 Age Related Macular Degeneration (AMD) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Regeneron Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Age Related Macular Degeneration (AMD) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

2.5 Valeant

2.5.1 Business Overview

2.5.2 Age Related Macular Degeneration (AMD) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Valeant Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

2.6 Pfizer

2.6.1 Business Overview

2.6.2 Age Related Macular Degeneration (AMD) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pfizer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Age Related Macular Degeneration (AMD) Market Competition, by Players

3.1 Global Age Related Macular Degeneration (AMD) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Age Related Macular Degeneration (AMD) Players Market Share

3.2.2 Top 10 Age Related Macular Degeneration (AMD) Players Market Share

3.3 Market Competition Trend

4 Global Age Related Macular Degeneration (AMD) Market Size by Regions

4.1 Global Age Related Macular Degeneration (AMD) Revenue and Market Share by Regions

4.2 North America Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

4.3 Europe Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

4.5 South America Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

5 North America Age Related Macular Degeneration (AMD) Revenue by Countries

5.1 North America Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)

5.2 USA Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

5.3 Canada Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

5.4 Mexico Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

6 Europe Age Related Macular Degeneration (AMD) Revenue by Countries

6.1 Europe Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)

6.2 Germany Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

6.3 UK Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

6.4 France Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

6.5 Russia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

6.6 Italy Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue by Countries

7.1 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)

7.2 China Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

7.3 Japan Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

7.4 Korea Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

7.5 India Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

8 South America Age Related Macular Degeneration (AMD) Revenue by Countries

8.1 South America Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)

8.2 Brazil Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

8.3 Argentina Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

8.4 Colombia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Age Related Macular Degeneration (AMD) by Countries

9.1 Middle East and Africa Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

9.3 UAE Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

9.4 Egypt Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

9.6 South Africa Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

10 Global Age Related Macular Degeneration (AMD) Market Segment by Type

10.1 Global Age Related Macular Degeneration (AMD) Revenue and Market Share by Type (2013-2018)

10.2 Global Age Related Macular Degeneration (AMD) Market Forecast by Type (2018-2023)

10.3 Wet AMD Revenue Growth Rate (2013-2023)

10.4 Dry AMD Revenue Growth Rate (2013-2023)

11 Global Age Related Macular Degeneration (AMD) Market Segment by Application

11.1 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2013-2018)

11.2 Age Related Macular Degeneration (AMD) Market Forecast by Application (2018-2023)

11.3 Men Revenue Growth (2013-2018)

11.4 Woman Revenue Growth (2013-2018)

12 Global Age Related Macular Degeneration (AMD) Market Size Forecast (2018-2023)

12.1 Global Age Related Macular Degeneration (AMD) Market Size Forecast (2018-2023)

12.2 Global Age Related Macular Degeneration (AMD) Market Forecast by Regions (2018-2023)

12.3 North America Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)

12.4 Europe Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)

12.6 South America Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Age Related Macular Degeneration (AMD) Picture

Table Product Specifications of Age Related Macular Degeneration (AMD)

Table Global Age Related Macular Degeneration (AMD) and Revenue (Million USD) Market Split by Product Type

Figure Global Age Related Macular Degeneration (AMD) Revenue Market Share by Types in 2017

Figure Wet AMD Picture

Figure Dry AMD Picture

Table Global Age Related Macular Degeneration (AMD) Revenue (Million USD) by Application (2013-2023)

Figure Age Related Macular Degeneration (AMD) Revenue Market Share by Applications in 2017

Figure Men Picture

Figure Woman Picture

Table Global Market Age Related Macular Degeneration (AMD) Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2013-2023)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Age Related Macular Degeneration (AMD) Type and Applications

Table Bayer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

Table F. HoffmannLa Roche Basic Information, Manufacturing Base and Competitors

Table F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Type and Applications

Table F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

Table Regeneron Basic Information, Manufacturing Base and Competitors

Table Regeneron Age Related Macular Degeneration (AMD) Type and Applications

Table Regeneron Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Age Related Macular Degeneration (AMD) Type and Applications

Table Novartis Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

Table Valeant Basic Information, Manufacturing Base and Competitors

Table Valeant Age Related Macular Degeneration (AMD) Type and Applications

Table Valeant Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Age Related Macular Degeneration (AMD) Type and Applications

Table Pfizer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2016-2017)

Table Global Age Related Macular Degeneration (AMD) Revenue (Million USD) by Players (2013-2018)

Table Global Age Related Macular Degeneration (AMD) Revenue Share by Players (2013-2018)

Figure Global Age Related Macular Degeneration (AMD) Revenue Share by Players in 2016

Figure Global Age Related Macular Degeneration (AMD) Revenue Share by Players in 2017

Figure Global Top 5 Players Age Related Macular Degeneration (AMD) Revenue Market Share in 2017

Figure Global Top 10 Players Age Related Macular Degeneration (AMD) Revenue Market Share in 2017

Figure Global Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Age Related Macular Degeneration (AMD) Revenue (Million USD) by Regions (2013-2018)

Table Global Age Related Macular Degeneration (AMD) Revenue Market Share by Regions (2013-2018)

Figure Global Age Related Macular Degeneration (AMD) Revenue Market Share by Regions (2013-2018)

Figure Global Age Related Macular Degeneration (AMD) Revenue Market Share by Regions in 2017

Figure North America Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Europe Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure South America Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Table North America Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)

Table North America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2013-2018)

Figure North America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2013-2018)

Figure North America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2017

Figure USA Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Canada Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Mexico Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Table Europe Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2013-2018)

Figure Europe Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2013-2018)

Figure Europe Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2017

Figure Germany Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure UK Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure France Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Russia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Italy Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2017

Figure China Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Japan Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Korea Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure India Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Table South America Age Related Macular Degeneration (AMD) Revenue by Countries (2013-2018)

Table South America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2013-2018)

Figure South America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2013-2018)

Figure South America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2017

Figure Brazil Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Argentina Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Colombia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure UAE Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Egypt Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure Nigeria Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Figure South Africa Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2013-2018)

Table Global Age Related Macular Degeneration (AMD) Revenue (Million USD) by Type (2013-2018)

Table Global Age Related Macular Degeneration (AMD) Revenue Share by Type (2013-2018)

Figure Global Age Related Macular Degeneration (AMD) Revenue Share by Type (2013-2018)

Figure Global Age Related Macular Degeneration (AMD) Revenue Share by Type in 2017

Table Global Age Related Macular Degeneration (AMD) Revenue Forecast by Type (2018-2023)

Figure Global Age Related Macular Degeneration (AMD) Market Share Forecast by Type (2018-2023)

Figure Global Wet AMD Revenue Growth Rate (2013-2018)

Figure Global Dry AMD Revenue Growth Rate (2013-2018)

Table Global Age Related Macular Degeneration (AMD) Revenue by Application (2013-2018)

Table Global Age Related Macular Degeneration (AMD) Revenue Share by Application (2013-2018)

Figure Global Age Related Macular Degeneration (AMD) Revenue Share by Application (2013-2018)

Figure Global Age Related Macular Degeneration (AMD) Revenue Share by Application in 2017

Table Global Age Related Macular Degeneration (AMD) Revenue Forecast by Application (2018-2023)

Figure Global Age Related Macular Degeneration (AMD) Market Share Forecast by Application (2018-2023)

Figure Global Men Revenue Growth Rate (2013-2018)

Figure Global Woman Revenue Growth Rate (2013-2018)

Figure Global Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Age Related Macular Degeneration (AMD) Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Age Related Macular Degeneration (AMD) Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)

Figure Europe Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)

Figure South America Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
View Details
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
View Details
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research